Home
Home

AMPYRA

Acorda Drug Helps Stroke Patients Walk Better

Acorda Drug Helps Stroke Patients Walk Better
TheStreet.com

Potentially game changing data awaits Acorda in 2013

Potentially game changing data awaits Acorda in 2013
Reuters

Acorda sinks after insurance provider questions MS drug

Acorda sinks after insurance provider questions MS drug
Yahoo/Fly on the Wall

Acorda: Volatility Expected On Upcoming Trial Results For Lower Ampyra Dose

Acorda: Volatility Expected On Upcoming Trial Results For Lower Ampyra Dose
Yahoo/Reuters

Acorda Therapeutics To FDA: What Deadlines?

Acorda Therapeutics To FDA: What Deadlines?
Pharmalot

5 Biotech Drug-Launch Stocks to Watch

5 Biotech Drug-Launch Stocks to Watch
TheStreet.com

Acorda Pushes Sales of MS Drug

Acorda Pushes Sales of MS Drug
Minyanville

Analyst raises Acorda target as Ampyra sales grow

Analyst raises Acorda target as Ampyra sales grow
Yahoo/AP

News

Acorda’s Ampyra Runs Ahead of Other MS Treatments
Minyanville
»

News

Seven Biotech Drugs to Watch in the Second Quarter
BNET Pharma
»